What meds are Canadians taking? Insights from Telus Health’s 2024 Drug Data Trends and National Benchmarks reportData on diabetes, dermatology and depression and more in this latest report that examines how much drug plans spend on different medications each year. Don’t dismiss the usefulness of osteoporosis medication after age 70: study POP QUIZ: Nurtec ODT for migraine Can you figure out which statement about this newly approved treatment? Health Canada has approved Keytruda for gastric cancer Keytruda and chemotherapy were found to increase median overall survival to 12.9 months, compared with 11.5 months on just chemotherapy. Donepezil not associated with increased risk of proarrhythmic cardiac events Researchers say the finding could also help ease administrative burden for those prescribing this common medication for dementia. Diltiazem increases bleeding risk in older adults receiving apixaban or rivaroxaban Diltiazem used for ventricular rate control in patients with atrial fibrillation inhibits apixaban and rivaroxaban elimination, possibly causing overanticoagulation. POP QUIZ: Insomnia in youth Which statement would NOT be good advice for managing insomnia in an adolescent? Can oral minoxidil be used instead of topical minoxidil for male pattern baldness? A 24-week randomized clinical trial compares low-dose oral minoxidil and topical minoxidil solution for male androgenetic alopecia. Can ketamine treat substance use disorders? A CADTH review looks into the evidence amid increased interest in using ketamine to treat mental illnesses. Rimegepant (Nurtec ODT) now available for acute treatment of migraine Rimegepant is the second oral “gepant” for acute migraine to be marketed in Canada following ubrogepant (Ubrelvy). First Previous 31 32 33 34 35 Next Last
